Croda Pharma Breaks Ground on Excipients Manufacturing Facility

URLhttps://www.biopharminternational.com/view/croda-p
SourceBio Pharma International.com
Date Published06/14/2023
Author NameGrant Playter

Additional Reshoring Information:

Company/Division name Croda Pharma
Parent companyCroda Pharma
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2023
Year reshoring implemented or to be implemented:2025
City reshored to:Lamar
State(s) reshored to:PA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshored mRNA vaccines and gene editing therapies
What domestic positive factors made reshoring more attractive?Eco-system synergies
Find Reshoring Articles